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Abstract
In ascidian embryos, a fibroblast growth factor (FGF) signal induces notochord, mesenchyme, and brain formation. Although a conserved
Ras/MAPK pathway is known to be involved in this signaling, the target transcription factor of this signaling cascade has remained
unknown. We have isolated HrEts, an ascidian homolog of vertebrate Ets1 and Ets2, to elucidate the transcription factor involved in the FGF
signaling pathway in embryos of the ascidian Halocynthia roretzi. Maternal mRNA of HrEts was detected throughout the entire egg
cytoplasm and early embryos. Its zygotic expression started in several tissues, including the notochord and neural plate. Overexpression of
HrEts mRNA did not affect the general organization of the tadpoles, but resulted in formation of excess sensory pigment cells. In contrast,
suppression of HrEts function by morpholino antisense oligonucleotide resulted in severe abnormalities, similar to those of embryos in
which the FGF signaling pathway was inhibited. Notochord-specific Brachyury expression at cleavage stage and notochord differentiation
at the tailbud stage were abrogated. Formation of mesenchyme cells was also suppressed, and the mesenchyme precursors assumed muscle
fate. In addition, expression of Otx in brain-lineage blastomeres was specifically suppressed. These results suggest that an Ets transcription
factor, HrEts, is involved in signal transduction of FGF commonly in notochord, mesenchyme, and brain induction in ascidian embryos.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
During animal embryogenesis, cell interactions mediated
by growth factors play crucial roles in tissue formation and
morphogenesis. This is also true for ascidian embryos,
which show invariant cell lineages and for a long time have
been regarded as a representative of mosaic development
(reviewed by Satoh, 1994; Nishida, 1997, 2002a). Cell in-
teractions start early in ascidian embryogenesis. At the
cleavage stages, notochord and mesenchyme fates are in-
duced by endoderm blastomeres that locate in the vegetal
pole region (Nakatani and Nishida, 1994; Kim and Nishida,
1999; Minokawa et al., 2001). It has also been shown that
inductive events are involved in the formation of the brain
(or sensory vesicle) of the tadpole (Okamura et al., 1993,
1994; Okada et al., 1997).
Various evidence suggests that FGF signaling is com-
monly required in notochord and mesenchyme induction in
ascidian development. The response to FGF, namely mak-
ing notochord or mesenchyme, simply depends on signal-
receiving blastomeres (Kim et al., 2000). Treatment of iso-
lated blastomeres with FGF, but not activin, induces
notochord and mesenchyme fates in the blastomeres whose
default fates are posterior nerve cord and muscle, respec-
tively (Nakatani et al., 1996; Kim et al., 2000; Minokawa et
al., 2001). Suppression of endogenous Ras function by
injection of a dominant-negative form of Ras inhibits noto-
chord and mesenchyme formation (Nakatani and Nishida,
1997; Kim and Nishida, 2001). The reduction of extracel-
lular signal- regulated kinase (ERK/MAPK) activity by
treatment with FGF receptor inhibitor or MEK (ERK ki-
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nase/MAPKK) inhibitor results in the failure of induction of
these tissues (Kim and Nishida, 2001). As a consequence of
FGF signaling, phosphorylated and activated MAPK accu-
mulates in the nuclei of notochord and mesenchyme pre-
cursor blastomeres just after inductive interaction (Nishida,
2002b).
Ascidian FGF and FGF receptor genes were isolated and
analyzed recently (Kamei, 2000; Shimauchi et al., 2001;
Imai et al., 2002). Maternal mRNA for Halocynthia FGF
receptor (HrFGFR) is present ubiquitously in early em-
bryos. When synthetic mRNA for the dominant- negative
form of HrFGFR is injected into fertilized eggs, the em-
bryos fail to form notochord and mesenchyme (Shimauchi
et al., 2001). On the other hand, an ascidian FGF gene
(Cs-FGF4/6/9) that is similar to vertebrate FGF4, FGF6,
FGF9, and FGF20 was isolated in Ciona savignyi. Cs-
FGF4/6/9 is expressed transiently in endodermal cells,
which are a source of inductive signal at the stage when the
induction of notochord and mesenchyme occurs. When the
Cs-FGF4/6/9 function is suppressed with a specific anti-
sense morpholino oligonucleotide, the formation of mesen-
chyme and notochord is reduced (Imai et al., 2002). There-
fore, FGF and its signaling pathway, including FGF
receptor, Ras, MEK, and MAPK, play essential roles in
notochord and mesenchyme induction in ascidians. Thus,
the signaling cascade is remarkably conserved among mes-
enchyme and notochord inductions during ascidian embry-
ogenesis, as well as among FGF signaling in other organ-
isms that have been studied. But mesenchyme and
notochord blastomeres show distinct responses to the same
FGF signal, indicating that a cell’s response to a signal
depends on its internal state.
Induction of notochord takes place at the 32-cell stage
and triggers the expression of the Brachyury gene (HrBra)
from the 64-cell stage (Nakatani et al., 1996). HrBra is
expressed exclusively in notochord precursors immediately
after the induction (Yasuo and Satoh 1993, 1994), and is a
key regulator gene for notochord differentiation in ascidian
embryos (Yasuo and Satoh, 1998; Takahashi et al., 1999).
In mesenchyme induction, FGF signaling at the 32-cell
stage immediately downregulates the expression of a muscle
actin gene (HrMA4) in mesenchyme precursor blastomeres
of 64-cell embryos (Satou et al., 1995; Kim and Nishida,
1999; Kim et al., 2000).
The tadpole larvae of ascidians have a brain (or sensory
vesicle) in the cranial region. The brain is derived from the
anterior–animal (a-line) blastomeres. The other part of the
central nervous system, the posterior nerve cord, originates
from the anterior–vegetal (A-line) blastomeres (Nishida,
1997). The formation of the brain and neurons within it
depends on inductive signals from the vegetal hemisphere
(Okamura et al., 1993, 1994; Okada et al., 1997). Recently,
evidence has been accumulating to suggest that FGF plays
a critical role in brain induction in ascidians. FGF treatment
induces expression of a sodium channel gene in isolated
brain precursors, but treatment with TGF, activin, EGF,
and NGF has no effect (Inazawa et al., 1998). FGF treat-
ment also suppresses the expression of epidermis markers
and induces the expression of genes for an early neural plate
marker, HrETR-1, and a nervous-system-specific tubulin,
HrTBB2 (Darras and Nishida, 2001). The requirement for
FGF signaling in neural induction was shown by injecting
with dominant-negative Ras and by treatment with inhibi-
tors of FGFR and MEK by monitoring HrETR-1 expression
(Kim and Nishida, 2001). Activated MAPK also accumu-
lates in the nuclei of brain precursor blastomeres after the
32-cell stage (Nishida, 2002b).
Orthodenticle/Otx is a homeobox transcription factor
that is known to play important roles in brain develop-
ment in Drosophila and vertebrates (Simeone, 1998). In
ascidians, the expression of its homolog is initiated in the
brain lineage at the 32-cell stage (Wada et al., 1996;
Hudson and Lemaire, 2001). When the Halocynthia Otx
gene, Hroth, is introduced into a Drosophila orthoden-
ticle mutant, the ascidian gene can rescue brain defects in
Drosophila (Adachi et al., 2001). Therefore, the function
of this gene is conserved across different phyla. The
expression in a- line blastomeres depends on contact with
vegetal blastomeres. Overexpression of Hroth in ascid-
ians results in expansion of the nervous-system-specific
tubulin expression domain. It also causes autonomous
expression of nervous-system-specific tubulin in isolated
a-line blastomeres (Wada and Saiga, 1999). Therefore,
Otx would be one of the key transcription factors that
function downstream in the complex pathway involving
brain induction. Recently, it has been shown that FGF
treatment induces expression of an Otx homolog in iso-
lated a-line brain precursors (Darras and Nishida, 2001;
Hudson and Lemaire, 2001; Hudson et al., 2002).
Thus, FGF signaling immediately results in transcrip-
tional control of brachyury in notochord, muscle actin in
mesenchyme, and Otx in brain. However, transcription fac-
tors that are activated by FGF signaling are still unknown.
It would be interesting to know whether different transcrip-
tion factors are activated by MAPK in the induction of these
three cell types or whether a common transcription factor is
utilized in all of these inductions. The present study was
undertaken to identify transcription factors that are the tar-
get of the FGF-Ras-MAPK signaling pathway in ascidian
development. The Ets family of transcription factors is
known as one of the targets of the Ras-MAPK signaling
pathway (reviewed by Wasylyk et al., 1998; Yordy and
Muise-Helmericks, 2000). The family is defined by a con-
served DNA-binding domain (Ets DNA-binding domain).
More than 30 members have now been found in diverse
species and have been implicated in a variety of biological
events in development. Within several subgroups of Ets
factors, members of the ETS subgroup, which includes
vertebrate Ets1, Ets2, and Drosophila Pointed P2, have a
single MAPK phosphorylation site on a threonine residue,
and phosphorylation by MAPK controls their activity
(Brunner et al., 1994; Wasylyk et al., 1997). On the other
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hand, members of another subgroup, ternary complex fac-
tors (TCFs), which includes Elk1, Sap1a, Sap1b, Fli1, and
Net, contain a transactivation domain that can be phosphor-
ylated on multiple serine and threonine residues (Hipskind
et al., 1994; Treisman, 1994).
In the present study, we isolated HrEts, a Halocynthia
homolog of vertebrate Ets1 and Ets2, and analyzed HrEts
functions. The results suggest that HrEts protein functions
as a target transcription factor of FGF signaling and is
commonly utilized in induction of notochord, mesenchyme,
and brain in ascidian embryos.
Materials and methods
Animals and embryos
Adults of Halocynthia roretzi were collected or pur-
chased from fishermen near the Otsuchi Marine Research
Center, University of Tokyo, Iwate, Japan, and near the
Asamushi Marine Biological Station, Tohoku University,
Aomori, Japan. Naturally spawned eggs were fertilized with
a suspension of non-self sperm. They developed into gas-
trulae and early tailbud embryos at approximately 12 and
24 h, respectively, after fertilization at 12°C. Tadpole larvae
hatched at 40 h of development.
Cloning of HrEts
PCR was used to isolate fragments of HrEts cDNAs.
Degenerate primers were designed to cover conserved Ets
DNA-binding domain: forward primer, 5-CCIATHCAR-
YTNTGGCARTT-3; reverse primer, 5-CAIACRAAICK-
RTANACRTA-3. The targeted template was a reverse-
transcription product of H. roretzi 110-cell-stage embryos.
Resultant fragments were subcloned into pBluescript SK
(Stratagene) and sequenced. We found that one of them
encoded a polypeptide corresponding to an Ets DNA-bind-
ing domain. This fragment was used to screen an H. roretzi
110- cell-stage cDNA library. The longest clone we ob-
tained was 3951 bp long and included 18 adenyl residues at
the 3 end. Nucleotide sequences were determined for both
strands with a SequiTherm Excel II Kit (Epicentre Tech-
nologies, USA) and a LIC-4000 DNA sequencer (Li-Cor
Biosciences, USA). The cDNA sequence containing a pu-
tative open reading frame of 791 amino acids will appear
under the Accession No. AB092968 in the DDBJ/EMBL/
GenBank nucleotide sequence database.
In situ hybridization and detection of tissue-specific
markers
Whole-mount in situ hybridization was carried out as
described by Miya et al. (1997). After hybridization, the
Fig. 1. Schematic representation of HrEts (GenBank Accession No. AB092968), mouse Ets1 (P27577), mouse Ets2 (P15037), sea urchin Ets (AAA30048),
and Drosophila Pointed P2 (CAA48917). The Pointed domain, Ets DNA-binding domain, and percentage of amino acid identity with HrEts are indicated.
The conserved threonine residue (T) that is phosphorylated by MAPK is also indicated.
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specimens were washed in 50% formamide, 2 SSC, 1%
SDS (15 min, 50°C). The specimens were then digested
with 10 g/mL RNase A in 2 SSC, 0.1% Tween 20, (20
min, 37°C), then washed in 2 SSC, 0.1% Tween 20 (2 
20 min, 50°C) and 0.2 SSC, 0.1% Tween 20 (2  20 min,
37°C). The specimens were finally washed twice in PBS
containing 0.1% Tween 20 at room temperature and visu-
alized by using the alkaline phosphatase reaction. RNA
probes were prepared with a DIG RNA labeling kit
(Boehringer-Mannheim). In this study, we examined the
expression of following genes: HrBra (As-T; Yasuo, 1994),
HrMA4 (Satou et al., 1995), and Hroth (Wada et al., 1996)
encode Halocynthia homologues of Brachyury, larval mus-
cle actin, and Otx, respectively. HrETR-1 (Yagi and Mak-
abe, 2001) encodes an elav-related gene that is specifically
expressed in the neural plate.
Detection of tissue-specific markers was performed as
described by Kim and Nishida (2001). Specimens were
fixed in absolute methanol for 10 min at 20°C. Indirect
immunofluorescence detection was carried out by standard
methods using a TSA fluorescein system (Perkin-Elmer Life
Sciences) according to the manufacturer’s protocol. Forma-
tion of mesenchyme cells in the partial embryos was mon-
itored by staining with the Mch-3 monoclonal antibody.
Mch-3 specifically recognizes small particles in mesen-
chyme cells of Halocynthia larvae (Kim and Nishida 1999).
The monoclonal antibody Mu-2 was used for monitoring
muscle formation. Mu-2 recognizes the myosin heavy chain
in tail muscle cells of larvae (Nishikata et al., 1987a). The
monoclonal antibody Epi-2 recognizes larval epidermal
cells (Nishikata et al., 1987b). The monoclonal antibody
Not-1 recognizes differentiated notochord cells (Nishikata
and Satoh 1990). Formation of endoderm was monitored by
histochemical detection of alkaline phosphatase (ALP) ac-
tivity using the method described by Whittaker and Meedel
(1989) with 5-bromo-4-chloro-3-indolyl phosphate as the
substrate.
Synthetic mRNA and morpholino oligonucleotide
The entire ORF of HrEts was cloned into the pBlue-
scriptHTB transcription vector, which contains both 5 and
3 UTRs of HrTBB2, a Halocynthia beta-tubulin gene (T.
Fig. 2. Expression pattern of HrEts during development. Anterior is to the
left in (A) and (I), and up in (B–H). (A) A fertilized egg after ooplasmic
segregation. This specimen was cleared by xylene treatment. HrEts ma-
ternal mRNA was detected throughout the egg cytoplasm. Some of the
mRNA was concentrated in the posterior–vegetal region (arrow). (B) An
8-cell-stage embryo, animal view. HrEts maternal mRNA was partitioned
into every blastomere. In addition, the mRNA was accumulated in the
postplasmic region (arrowheads). (C, D) Animal (C) and vegetal (D) views
of a 32-cell-stage embryo. Zygotic expression of HrEts was detected
around the nuclei of the vegetal blastomeres in (D). Accumulation of the
mRNA in the postplasmic region is indicated by a white arrowhead in (C).
(E, F) Animal (E) and vegetal (F) views of a 110-cell-stage embryo. HrEts
expression was apparent in the nerve cord precursor cells (arrow). (G, H)
Dorsal (G) and ventral (H) view of a neural-plate-stage embryo (NP).
HrEts was expressed in the cells at the edge of the neural plate (arrow) and
in the posterior cells. (I) Lateral view of a tailbud embryo (TB). HrEts was
expressed in the notochord (black arrow) and dorsal epidermis (white
arrow). Scale bar, 100 m.
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Akanuma and H. N., unpublished data). To introduce a
frameshift mutation in order to make the control construct,
we digested the clone with restriction enzyme EcoRI, of
which a single restriction site exists within the Ets DNA-
binding domain. The protrusion of the EcoRI site was filled
by T4 DNA polymerase, then the clone was self-ligated.
This resulted in generation of eight altered amino acids and
a stop codon in the 5 end of the frameshifted region (see
Fig. 3A). To synthesize the mRNA, the recombinant plas-
mid was linearized with XhoI and transcribed with T3 poly-
merase in the presence of m7G(5)ppp(5)G using an
mMessenger mMachine kit (Ambion, USA). Synthetic
mRNA (200 pg) was injected into fertilized eggs. To sup-
press the HrEts function, we used a 25- mer morpholino
oligonucleotide (M-oligo; Gene Tools, Corvallis, OR,
USA). The nucleotide sequence of the M-oligo was 5-
TCATGGCGACCTTGGCCTGAAGATG-3, that covered
the first methionine codon of HrEts (see Fig. 4A). For
control experiments, we used standard control M- oligo
supplied by Gene Tools. M-oligo (2000 pg) was injected
into fertilized eggs. Eggs were allowed to develop until
appropriate stages, then they were fixed, and tissue forma-
tion was monitored.
Results
Expression pattern of HrEts
To isolate an ascidian homolog of the Ets transcription
factor, we designed two degenerate oligonucleotide primers
that correspond to conserved sequences within the C-termi-
nal DNA- binding domain. Using these primers, PCR frag-
ments were amplified from H. roretzi cDNA of 110-cell-
stage embryos. The resulting RT-PCR fragment was used to
screen a 110-cell-stage cDNA library. The longest clone we
obtained contained a putative ORF of 791 amino acids. We
designated the gene as HrEts (Halocynthia roretzi ho-
molog). HrEts contained a well conserved C-terminal DNA-
binding domain as well as an N-terminal domain, referred to
Fig. 3. Effects of HrEts overexpression on embryogenesis. (A) Diagram of synthetic mRNA used for microinjection. In HrEtsFS, a frame shift was introduced
into the DNA-binding domain. (B) A control larva developed from an egg injected with frame-shifted HrEtsFS mRNA. Two sensory pigment cells were
formed (arrow). (C) A larva developed from an egg injected with HrEts mRNA. Four pigment cells are visible (arrow).
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as the Pointed domain, which is conserved among vertebrate
Ets1, Ets2, sea urchin Ets, and Drosophila Pointed P2 (Fig.
1). This group of Ets family members has a single threonine
residue acting as a MAPK phosphorylation site located near
the Pointed domain (Brunner et al., 1994; Wasylyk et al.,
1997). We found a conserved threonine residue located near
the Pointed domain of HrEts (T in Fig. 1).
In situ hybridization analysis revealed that a significant
amount of maternal transcripts of HrEts is present through-
out the egg cytoplasm (Fig. 2A). A higher level of staining
was detected in the posterior–vegetal cytoplasm of fertilized
eggs after completion of the ooplasmic segregation (Fig.
2A, arrow). Essentially, maternal transcripts are inherited
by every blastomere in early embryos. In addition, the
posterior concentration of HrEts mRNA to the postplasmic
region (Sasakura et al., 2000) was visible from the 8- to
32-cell stage (Fig. 2B and C, arrowheads). Zygotic expres-
sion of HrEts was first detected in the vegetal blastomeres
of 32-cell-stage embryos (Fig. 2D). At the 110- cell stage,
HrEts was expressed in the anterior–vegetal blastomeres
that give rise to the nerve cord of the larva (Fig. 2F, white
arrow). At the neural plate stage, HrEts expression was
detected at the edge of the neural plate (Fig. 2G, black
arrow) and in some cells located inside the region posterior
to the gastropore (Fig. 2G and H). In the tailbud embryos,
HrEts was expressed in the notochord (Fig. 2I, black arrow)
and in the dorsal epidermis that overlies the nerve cord (Fig.
2I, white arrow).
Excess sensory pigment cells were produced by injection
of HrEts mRNA
To determine the function of HrEts in ascidian develop-
ment, we first examined the effects of its overexpression.
We injected 200 pg of synthetic HrEts mRNA and frame-
shifted HrEts (HrEtsFS) mRNA as a control (Fig. 3A) into
fertilized eggs. Embryos injected with HrEts mRNA
showed no abnormality in gastrulation or neurulation, and
developed into larvae with almost normal morphology.
However, they produced extra pigment cells in the cranial
region (Table 1). Whereas normal ascidian larvae have two
sensory pigment cells, the otolith and ocellus (Fig. 3B),
most larvae injected with HrEts mRNA produced three or
more pigment cells (Fig. 3C). Injection of HrEtsFS mRNA
had no effect.
Inhibition of HrEts function resulted in tailless larvae
To inhibit HrEts function, we injected antisense M-oligo
into fertilized eggs. We designed M- oligo as shown in Fig.
4A. Most embryos injected with control M-oligo developed
normally (Table 2;Fig. 4B). Fertilized eggs injected with
HrEts M-oligo cleaved normally, but gastrulation was de-
layed. At the larval stage, they displayed a truncated axis,
and their tail did not elongate (Fig. 4C). In addition, they did
not have a morphologically identifiable brain vesicle or
sensory pigment cells. These morphological abnormalities
resembled those of embryos injected with the dominant-
negative form of Ras (Nakatani and Nishida, 1997) and of
embryos treated with inhibitors of FGF receptor or MEK
that inhibit the FGF signaling pathway (Kim and Nishida,
2001) (Fig. 4F–H).
Table 1
Effects of injection of HrEts mRNA on number of sensory pigment cells
Neural tube
closed (%)
Neural tube not
closed (%)
n
Number of
pigmented
cells
Number of pigment
cells
3 2 3 2 1
HrEtsFS mRNA
(control, 200
pg)
0 87 7 0 6 54
HrEts mRNA
(200 pg)
82 3 11 3 0 61
Note. A small proportion of larvae failed in neural tube closure in both
treatments. This is likely a nonspecific effect of injection.
Table 2
Effect of HrEts antisense morpholino oligonucleotide on tail formation and pigment cell formation
Normal larva (%) Long tail but neural
tube not closed (%)
Short tail
(%)
Tail not
elongated (%)
n
2 pigment cells 1 or 2
pigment cells
No pigment
cells
No pigment
cells
Control MO (2000 pg) 75 25 0 0 0 67
HrEts MO (2000 pg) 0 0 0 0 100 61
HrEts MO (2000 pg) 
HrEtsFS mRNA (control,
200 pg)
0 0 7 0 93 44
HrEts MO (2000 pg) 
HrEts mRNA (200 pg)
0 0 25 63 12 52
Note. MO, morpholino oligonucleotide (M-oligo). In the lower half of this table, M-oligo was injected together with synthetic mRNA into fertilized eggs
in rescue experiments.
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To examine whether the effect is specifically caused by
suppression of HrEts translation, rescue experiments were
carried out. Synthetic HrEts mRNA has only nine (of 25)
bases overlapping with M-oligo (Fig. 4A), and is not sup-
posed to bind to M-oligo. We injected synthetic HrEts
mRNA into fertilized eggs together with M-oligo. This
coinjection partially rescued the tail formation in 88% of
experimental embryos, and pigment cells were formed in
25% of the cases (Fig. 4D; Table 2). On the other hand,
coinjection of HrEtsFS mRNA had no appreciable rescue
activity (Fig. 4E). This result excludes the residual possi-
bility that the rescue activity of synthetic HrEts mRNA is
due to absorption of M-oligo by the injected mRNA through
binding with the nine overlapping bases. Thus, effects of
M-oligo are likely to be specifically caused by suppression
of HrEts translation.
HrEts is required for notochord and mesenchyme
formation
We then examined tissue differentiation in embryos de-
veloped from eggs injected with HrEts M-oligo (Table 3).
Notochord formation was monitored by observing expres-
sion of the notochord- specific Not-1 antigen (Fig. 5A–D).
Expression of the Not-1 antigen was detected in the noto-
chord cells of uninjected embryos (Fig. 5A). In contrast,
59% (17 of 29) of M-oligo-injected embryos showed no
expression of the antigen (Fig. 5B), and 34% (10 of 29
embryos) showed weak expression of Not-1 in only a small
number of cells (Fig. 5C). The specificity of HrEts M-oligo
was confirmed in rescue experiments by coinjection of
HrEts mRNA. When HrEts M-oligo and HrEts mRNA were
coinjected, the expression of Not-1 antigen was restored in
all 18 cases (Fig. 5D).
Mesenchyme formation was examined by monitoring
expression of Mch-3, a mesenchyme- specific antigen.
Mch-3 antigen is expressed in the mesenchyme cells located
in the lateral region of the trunk of larvae (Fig. 5E, arrow).
The expression of Mch-3 was suppressed in most experi-
mental embryos injected with HrEts M-oligo (19 of 20
cases; Fig. 5F). In contrast, all M- oligo-injected embryos
expressed muscle myosin (23 cases; Fig. 5G and H), epi-
dermis-specific antigen, Epi-2 (22 cases; Fig. 5I and J), and
endoderm-specific alkaline phosphatase (12 cases; Fig. 5K
and L). This observation shows that M-oligo did not affect
the formation of those tissues in which FGF signaling is not
required.
Then, we examined the expression of tissue-specific
genes in the 110-cell embryos to investigate early effects of
M-oligo. Induction of notochord takes place at the 32-cell
stage, and triggers the expression the Brachyury (HrBra)
gene at the 64-cell stage (Nakatani et al., 1996). HrBra is a
key regulator gene for notochord differentiation in ascidian
embryos and is expressed exclusively in notochord precur-
sors immediately after notochord induction (Yasuo and Sa-
toh, 1993, 1994). In the 110-cell embryos, HrBra is ex-
pressed in 10 notochord precursor cells (Fig. 6A). In
contrast, the number of HrBra-expressing blastomeres was
significantly reduced in 67% (14 of 21) of embryos injected
with HrEts M-oligo (Fig. 6B), and no blastomere expressed
HrBra in 33% (7 of 21) of embryos (Fig. 6C). The suppres-
sion of HrBra expression was restored by coinjection of
HrEts mRNA. HrBra was normally expressed in 77% (10 of
13) of experimental embryos (Fig. 6D), and reduced expres-
Fig. 4. Effects of HrEts M-oligo (HrEts MO). (A) Diagram of HrEts M-oligo and 5 end of synthetic mRNA. M-oligo covers the first methionine codon.
(B) A control larva developed from an egg injected with standard control M-oligo. (C) A larva developed from an egg injected with HrEts M-oligo. The axis
was truncated. No pigment cell was formed. (D) A larva developed from an egg coinjected with HrEts M-oligo and HrEts mRNA. Formation of a tail and
pigment cells (arrowhead) was restored. (E) A larva developed from an egg coinjected with HrEts M-oligo and HrEtsFS mRNA. (F–H) FGF signaling was
inhibited by treatment of embryos with an FGF receptor inhibitor (F), dominant-negative Ras protein (G), and a MEK inhibitor (H). Photos in (F–H) are from
Kim and Nishida (2001) with permission.
Table 3
Effect of HrEts antisense morpholino oligonucleotide on formation of various tissues
Tissue types Markers n Absent Reduced Normal
HrEts MO notochord Not-1 29 17 10 2
HrEts MO  HrEts mRNA notochord Not-1 18 — — 18
HrEts MO notochord HrBra 21 7 14 —
HrEts MO  HrEts mRNA notochord HrBra 13 — 3 10
HrEts MO mesenchyme Mch-3 20 19 — 1
HrEts MO mesenchyme muscle actin 20 17: ectopic 3: normal
HrEts MO  HrEts mRNA mesenchyme muscle actin 12 0: ectopic 12: normal
HrEts MO brain Hroth 15 14 — 1
HrEts MO muscle myosin 23 — — 23
HrEts MO epidermis Epi-2 22 — — 22
HrEts MO endoderm ALP 12 — — 12
Note. MO, morpholino oligonucleotide (M-oligo). In rescue experiments, M-oligo was injected together with synthetic mRNA. ALP, alkaline phosphatase.
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sion was detected in the rest (3 of 13). Similar inhibition of
HrBra expression has been observed in embryos that are
treated with MEK inhibitor (U0126) to suppress MAPK
activation (Kim and Nishida, 2001), and we reconfirmed
this (Fig. 6E).
Expression of muscle actin (HrMA4) gene was examined
at the 110-cell stage. Mesenchyme precursors assume mus-
cle fate when FGF signaling pathways are inhibited (Kim
and Nishida, 2001; Imai et al., 2002). In normal embryos,
actin expression was observed in 10 primary muscle pre-
cursor blastomeres (Fig. 6F). As expected, additional ex-
pression of muscle actin was also observed in 4 mesen-
chyme precursor cells in 85% (17 of 20) of M-oligo-injected
embryos (Fig. 6G, arrowheads). This ectopic expression of
muscle actin was suppressed by coinjection of HrEts
mRNA, and the expression pattern became normal in all 12
cases (Fig. 6H). Ectopic expression of the actin gene in
mesenchyme blastomeres has also been observed in em-
bryos that are treated with MEK inhibitor (Kim and Nishida,
2001), and this was reconfirmed (Fig. 6I). Thus, inhibition
of HrEts function results in similar abnormalities as are
observed when MAPK activity is inhibited.
HrEts is required for Otx expression in brain-lineage
blastomeres
M-oligo-injected larvae did not have a morphological
brain vesicle (Fig. 4C). Therefore, we examined the expres-
sion of a neural-tissue-specific marker, HrETR-1 (Yagi and
Makabe, 2001), in tailbud embryos by in situ hybridization
(Fig. 7A and B). Although we detected HrETR-1 expression
in all 19 M-oligo-injected larvae, it was hard to tell whether
it was expressed in the brain or in the posterior nerve cord,
because the morphology of embryos and the expression
pattern were so disturbed (Fig. 7B).
Therefore, we examined early expression of Hroth, an
Otx homolog in Halocynthia, at cleavage stages (Table 3).
In ascidians, expression of the Otx homolog is initiated in
both the brain lineage blastomeres near the anterior edge of
the animal hemisphere and the endoderm lineage blas-
tomeres at the 32-cell stage (Fig. 7C and E) (Wada et al.,
1996; Hudson and Lemaire, 2001). In M-oligo- injected
embryos, Hroth expression in brain-lineage blastomeres
was suppressed at the 32- and 110-cell stages (Fig. 7D and
F, arrows) in all 8 cases and in 6 out of 7 cases, respectively.
In contrast, the expression of endoderm-lineage blastomeres
was not affected in any cases. This observation indicates
that regulation of Hroth expression differs between lin-
eages, and that only Hroth expression in the brain-lineage
requires HrEts activity.
Fig. 5. Effects of HrEts M-oligo on expression of tissue differentiation
markers. (A, E, G, I, K) Control embryos developed from uninjected eggs.
(B, C, F, H, J, L) HrEts M-oligo was injected. (D) HrEts M-oligo and its
mRNA were coinjected. (A–D) Notochord-specific Not-1 antigen. Expres-
sion of Not-1 antigen was suppressed (B) or reduced (C) by injection of
HrEts M-oligo. (D) Coinjection of HrEts mRNA rescued the expression.
(E, F) Mesenchyme-specific Mch-3 antigen. Arrow in (E) indicates the
expression of Mch-3 antigen in the mesenchyme. (G, H) Muscle-specific
myosin. (I, J) Epidermis-specific Epi-2 antigen. (K, L) Endoderm-specific
alkaline phosphatase.
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Discussion
We isolated and characterized a gene for an ascidian Ets
family member, HrEts. Functional analysis demonstrated
that HrEts is commonly required for the formation of no-
tochord, mesenchyme, and brain. It is also likely involved in
sensory pigment cell formation.
HrEts is the ascidian homolog of vertebrate Ets1 and Ets2
The Ets family of transcription factors is defined by a
conserved DNA binding domain (Wasylyk et al., 1993).
Members are classified into at least six subfamilies [ETS,
YAN, ELG, PEA3, ERF, and ternary complex factor (TCF)]
by their structure and amino acid sequence similarity (Wa-
sylyk et al., 1998). In the Ets family, ETS subfamily mem-
bers (vertebrate Ets1, Ets2, Drosophila Pointed P2) possess
a conserved N-terminal regulatory domain (the Pointed do-
main) as well as a highly conserved C-terminal DNA-
binding domain (the Ets DNA-binding domain). This group
of Ets family members has a single MAPK phosphorylation
site located near the Pointed domain (Brunner et al., 1994;
Wasylyk et al., 1997). HrEts has all of these three charac-
teristics of the ETS subfamily, suggesting that HrEts is an
ascidian member of the ETS subfamily and is an ascidian
homolog of vertebrate Ets1 and Ets2. The presence of a
conserved MAPK phosphorylation site suggests that its ac-
tivity is also regulated by MAPK.
Maternal mRNA of HrEts exists in the fertilized eggs
and was detected throughout the entire embryo during early
cleavage stages. It is likely that the HrEts protein is trans-
lated and distributed in every blastomere, but is activated
only in the blastomeres that receive FGF and other inter-
cellular signals. The results of an HrEts overexpression
experiment support this idea. Injection of HrEts mRNA did
not affect the general organization of the tadpoles, such as
mesoderm and axis formation. So it seems that overex-
pressed HrEts would work only when it is activated by
signaling.
Although some amount of HrEts mRNA is localized in
the posterior–vegetal region of eggs and is concentrated to
the postplasmic region (Fig. 2A–D), the significance re-
mains unclear at the moment. After the 32-cell stage, HrEts
is expressed zygotically in various kinds of cells (Fig. 2E–
I). In mammalian development, Ets family genes are ex-
pressed in many tissues during development (Maroulakou
and Bowe, 2000). It is impossible to presume later functions
of HrEts from its expression pattern, because the activity of
Ets transcription factors is controlled by its phosphoryla-
tion, and because the inhibition of HrEts functions by M-
oligo caused severe abnormalities in early stages.
HrEts is involved in notochord and mesenchyme induction
Inductive interactions are required for notochord and
mesenchyme specification, and FGF and Ras/MAPK sig-
naling is involved in these processes (Nakatani and Nishida
1994; Nakatani et al., 1996; Kim and Nishida 1999; Kim et
al., 2000). In consequence, activated MAPK accumulates in
the nuclei of notochord and mesenchyme precursor blas-
tomeres just after inductive interaction (Nishida, 2002b).
Recently, an ascidian FGF receptor gene and an ascidian
FGF gene have been isolated and characterized (Shimauchi
et al., 2001; Imai et al., 2002). Functional analysis of these
genes provides direct evidence that FGF is involved in the
induction of notochord and mesenchyme. The results of the
present study suggest that HrEts is the transcription factor
that is likely activated by MAPK in the FGF signaling
cascade in early inductive events in ascidian embryos.
When HrEts M-oligo was injected into fertilized eggs,
the resultant embryos showed similar abnormalities to those
injected with dominant-negative Ras (Nakatani and
Nishida, 1997) and those treated with MEK inhibitor or
FGF receptor inhibitor (Kim and Nishida, 2001) in Halo-
cynthia. The specificity of the effects of M-oligo was vali-
dated in rescue experiments in which mRNA was coin-
jected. M-oligo-injected embryos lacked differentiated
notochord, and the expression of HrBra was suppressed.
The early effect on HrBra expression at cleavage stage
indicates that HrEts is required in early steps in notochord
formation, most plausibly notochord induction that takes
place at the 32-cell stage. Thus, it is likely that HrEts is
involved in notochord induction as a target of the Ras/
MAPK pathway of FGF signaling.
Mesenchyme precursors assume muscle fate without cell
interaction, and FGF signaling is involved in the mesen-
chyme induction (Kim and Nishida, 1999, 2001; Kim et al.,
2000; Imai et al., 2002). In the present study, the same result
was obtained by suppression of HrEts function. When
HrEts M-oligo was injected into fertilized eggs, formation
of mesenchyme was inhibited, and the ectopic expression of
muscle actin (HrMA4) gene was observed in mesenchyme
precursor cells. The early effect on the muscle actin expres-
sion and fate conversion of mesenchyme precursors to mus-
cle at cleavage stage indicate that HrEts is required in the
mesenchyme induction that takes place at the 32-cell stage.
Thus, it is likely that HrEts is a target of the Ras/MAPK
pathway of FGF signaling also in mesenchyme induction.
The data indicate that HrEts and FGF signaling are
involved in the same processes. So far, many studies have
shown that Ets acts downstream of MAP kinase in various
organisms; however, strictly speaking, the possibility that
HrEts could be required to activate FGF signaling at other
level cannot be excluded. Further experiments will be re-
quired to address this possibility.
Function of HrEts in brain induction
The brain of the ascidian larva is derived from the ante-
rior–animal (a-line) blastomeres. The other part of the cen-
tral nervous system, the posterior nerve cord, originates
from the anterior–vegetal (A-line) blastomeres (Nishida,
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1987). Specification of brain depends on inductive signals
from the vegetal hemisphere (Okamura et al., 1993, 1994;
Okada et al., 1997). In contrast, specification of the poste-
rior nerve cord is an autonomous process in ascidians
(Okada et al., 1997; Minokawa et al., 2001). FGF plays a
pivotal role in brain induction in ascidians (Inazawa et al.,
1998; Darras and Nishida, 2001; Kim and Nishida, 2001).
Activated MAPK accumulates also in the nuclei of brain
precursors at the cleavage stage (Nishida, 2002b). Consis-
tent with these reports, M- oligo-injected larvae lacked a
morphological brain vesicle. We observed that suppression
of HrEts function resulted in disturbance of the expression
pattern of a neural-plate marker gene, HrETR-1 (Fig. 7B).
However, it was difficult to distinguish the expression in the
brain or in the posterior nerve cord, since the morphology of
the resultant embryos was so disturbed.
Therefore, we examined early expression of Hroth, the
Otx homolog in Halocynthia, at cleavage stages. In ascid-
ians, the expression of Otx homolog is initiated in the brain
lineage and the endoderm lineage at the 32-cell stage (Wada
et al., 1996; Hudson and Lemaire, 2001). Otx would be a
key transcription factor whose transcription is activated by
brain induction (Wada and Saiga, 1999). Recently, it has
been shown that FGF treatment induces expression of the
Otx homolog in isolated a-line brain precursors (Darras and
Nishida, 2001; Hudson and Lemaire, 2001; Hudson et al.,
2002). The results of this study indicate that HrEts is re-
quired also for Hroth expression in brain lineage at the
cleavage stages. M-oligo injection specifically suppressed
Hroth expression in the brain lineage, while its expression
in the endoderm lineage was not affected at the 32- and
110-cell stages. Therefore, HrEts seems to transduce FGF
signaling also in brain induction in ascidian embryos.
Injection of HrEts M-oligo resulted in embryos lacking
sensory pigment cells. The abrogation of pigment cell for-
mation could be an indirect effect of absence of brain
induction because brain induction is a prerequisite for pig-
ment cell formation (Darras and Nishida, 2001). In contrast,
ectopic pigment cells were formed by overexpression of
HrEts mRNA (Fig. 3C). However, it is difficult to explain
why extra pigment cells were formed in HrEts-overex-
pressed embryos. One possibility is that an FGF signaling is
already present in relevant cells in the embryo and is capa-
ble of activating overexpressed HrEts in ectopic cells. An
alternative hypothesis is that the action of HrEts in pigment
cell formation might be different from its actions in early
embryonic induction and it might not need cell signaling.
FGF/Ras/MAPK signaling and HrEts are commonly
involved in three kinds of embryonic induction
The present results suggest that FGF signaling and its
downstream effector, Ets transcription factor, are commonly
utilized in notochord, mesenchyme, and brain induction (Fig.
8). The same signal is used to elicit different responses in
different blastomeres. This is consistent with the current view
of induction in developmental processes. The signaling mole-
cules available for inductive cell interactions in animal devel-
opment are limited. There are many examples of the same
ligands being used over and over again by different cells with
different outcomes. An extrinsic cue triggers a repertoire of
cell responses, and the developmental program achieved by the
signal- receiver cells depends on the intrinsic factors of the
cells. Intrinsic factors play roles in defining the “responsive-
ness” or “competence” of the cells. Thus, embryonic cells
respond differently to the same signaling molecule depending
on the spatial and temporal context. As for the formation of
notochord and mesenchyme in ascidians, it has been shown
that the posterior–vegetal cytoplasm (PVC) of the eggs causes
the difference in the responsiveness of notochord and mesen-
chyme precursor blastomeres (Kim et al., 2000). The PVC
factors are partitioned into mesenchyme blastomeres, but no-
tochord precursors do not inherit it. Removal of the PVC
results in loss of mesenchyme cells, and ectopic formation of
notochord takes place. In contrast, transplantation of the PVC
leads to ectopic formation of mesenchyme cells and loss of
notochord.
In FGF signaling in ascidian embryos, the signaling
cascade down to an effector transcription factor is com-
monly utilized in three kinds of embryonic induction. At
least, we found an Ets- binding consensus sequence in the 5
upstream region of HrMA4 gene in Halocynthia (H.N.,
unpublished data). There are two possible ways to modulate
the response of signal-receiver cells and to make the cell
response different depending on intrinsic factors. The Ets
transcription factor is known to interact with other transcrip-
tion factors to direct signals for transcription of specific
target genes (Sharrocks, 2001). For example, it has been
shown that mammalian Ets1 interacts with Pit-1, a pituitary-
specific POU-homeodomain protein, and activates the tran-
scription of pituitary-specific genes (Bradford et al., 1997).
Fig. 6. In situ hybridization of HrBra (A–E) and a muscle actin gene, HrMA4 (F–I), at the 110-cell stage. Vegetal views. Anterior is up. (A, F) Control
embryos developed from uninjected eggs. (B, C) Expression of HrBra was reduced (B) or suppressed (C) by injection of HrEts M-oligo. (D) Coinjection
of HrEts mRNA restored the expression. (E) MAPK activation was inhibited by treatment with 2 M MEK inhibitor, U0126. (G) Ectopic expression of
muscle actin was promoted in four mesenchyme precursor cells (arrowheads) by injection of HrEts M-oligo. (H) Coinjection of HrEts M-oligo and mRNA
restored the ectopic expression of muscle actin in the mesenchyme precursors. (I) MAPK activation was inhibited by treatment with MEK inhibitor.
Fig. 7. Effects of HrEts M-oligo on gene expression in nervous system. (A, C, E) Control embryos developed from uninjected eggs. (B, D, F) HrEts M-oligo
was injected. (A, B) Expression of a neural-plate-specific marker gene, HrETR-1, in tailbud embryos. (C–F) Expression of Hroth at the 32- (C, D) and 110-cell
(E, F) stages. Animal views (C, D) and vegetal views (E, F). Anterior is up. In M-oligo-injected embryos, Hroth expression in brain-lineage blastomeres at
the anterior margin (arrows) was specifically suppressed, but not in endoderm-lineage blastomeres.
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Another possibility is that inputs from the signal resulting in
Ets activation and from intrinsic PVC factors could be
combined at the level of regulatory regions of the target
genes without direct interaction of both Ets and PVC fac-
tors. Both factors might independently bind to the cis-
regulatory elements and cooperate to activate or silence the
target gene transcription. In future studies in developmental
biology, it will be important to understand how embryonic
cells can respond differently to the same signal, and how
cells integrate the intrinsic activity with the information
from extrinsic cues that are delivered into the cell by the
signal- transduction machinery. Ascidian embryos would
provide a good system to elucidate the issue.
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